[EN] MODIFIED CHLOROQUINES WITH BRANCHED MOIETY<br/>[FR] CHLOROQUINES MODIFIÉES À GROUPEMENTS RAMIFIÉS
申请人:DESIGNMEDIX INC
公开号:WO2010065925A1
公开(公告)日:2010-06-10
The disclosure provides modified chloroquine compounds having branched moieties. Also provided are pharmaceutical compositions comprising such compounds, methods of using such compounds to inhibit or treat diseases or conditions caused by chloroquine-resistant (CQR) and chloroquine-sensitive (CQS) malaria parasites and other CQ-susceptible microorganisms, and processes and intermediates useful for preparing such compounds
METHOD FOR PRODUCING N-METHYL-N-VINYLACETAMIDE HAVING IMPROVED STABILITY AND POLYMERIZABILITY
申请人:Showa Denko K.K.
公开号:EP2239250A1
公开(公告)日:2010-10-13
The present invention relates to a method for producing N-methyl-N-vinylacetamide, which comprises a step for controlling the N-1,3-butadienyl-N-methylacetamide content in N-methyl-N-vinylacetamide to 0.01-150 ppm. This method enables production of N-methyl-N-vinylacetamide having a stable quality, which can be controlled in stability and polymerizability as a monomer. N-methyl-N-vinylacetamide produced by the method enables production of an N-methyl-N-vinylacetamide polymer having stable physical properties such as a molecular weight.
The present invention is related to substituted amine derivatives notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such amine derivatives of formula (I). Said substituted amine derivatives are efficient modulators, in particular inhibitors, of the Bax function and/or activation. The present invention is furthermore related to novel substituted amine derivatives as well as methods of their preparation.
[EN] NOVEL THIAZOLE DERIVATES<br/>[FR] NOUVEAUX DERIVES DE THIAZOLE
申请人:HOFFMANN LA ROCHE
公开号:WO2005058887A1
公开(公告)日:2005-06-30
The present invention relates to compounds of formula (I)wherein R1, R2, R3 and R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof, for use as therapeutically active substances. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB 1 receptors.
N-(1-HYDROXYETHYL ) CARBOXAMIDE COMPOUND AND PROCESS FOR PRODUCING SAME
申请人:Ohta Keisuke
公开号:US20110294974A1
公开(公告)日:2011-12-01
The present invention relates to an N-(1-hydroxyethyl)carboxamide compound represented by formula (1)
(in the formula, R
A
and R
B
represent independently from each other a hydrogen atom or an alkyl group having 1 to 4 carbon atoms except for a case where R
A
and R
B
represent a hydrogen atom at the same time) and a method for producing the same; a method for producing an N-(1-alkoxyethyl)carboxamide compound; a method for producing an N-vinyl carboxylic acid amide compound; and a method for producing an N-vinyl carboxylic acid amide (co)polymer. An N-(1-alkoxyethyl)carboxamide compound can be obtained by reacting N-(1-hydroxyethyl)carboxamide compound with alcohol in the presence of an acid catalyst, and an N-vinyl carboxylic acid amide compound, which is a monomer of the N-vinyl carboxylic acid amide (co)polymer, can be obtained by thermally decomposing or catalytically decomposing the N-(1-alkoxyethyl)carboxamide compound.